FGF23 and chronic kidney disease: After initial clinical evidence of a link between high FGF23 levels and LVH in CKD nearly a decade ago, FGF23 is experimentally shown to phosphorylate phospholipase C gamma (PLCγ) via binding to FGFR isoform 4 on cardiac myocytes independent of Klotho.